- Home
- RVPH vs UONEK Comparison
RVPH vs UONEK Comparison
Compare RVPH & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- UONEK
- Stock Information
- Founded
- RVPH 2006
- UONEK 1980
- Country
- RVPH United States
- UONEK United States
- Employees
- RVPH N/A
- UONEK N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- UONEK Broadcasting
- Sector
- RVPH Health Care
- UONEK Consumer Discretionary
- Exchange
- RVPH Nasdaq
- UONEK Nasdaq
- Market Cap
- RVPH 26.6M
- UONEK 28.1M
- IPO Year
- RVPH N/A
- UONEK N/A
- Fundamental
- Price
- RVPH $0.54
- UONEK $0.73
- Analyst Decision
- RVPH Strong Buy
- UONEK
- Analyst Count
- RVPH 5
- UONEK 0
- Target Price
- RVPH $8.00
- UONEK N/A
- AVG Volume (30 Days)
- RVPH 2.8M
- UONEK 24.0K
- Earning Date
- RVPH 08-14-2025
- UONEK 08-13-2025
- Dividend Yield
- RVPH N/A
- UONEK N/A
- EPS Growth
- RVPH N/A
- UONEK N/A
- EPS
- RVPH N/A
- UONEK N/A
- Revenue
- RVPH N/A
- UONEK $411,386,000.00
- Revenue This Year
- RVPH N/A
- UONEK N/A
- Revenue Next Year
- RVPH N/A
- UONEK N/A
- P/E Ratio
- RVPH N/A
- UONEK N/A
- Revenue Growth
- RVPH N/A
- UONEK N/A
- 52 Week Low
- RVPH $0.30
- UONEK $0.44
- 52 Week High
- RVPH $4.28
- UONEK $1.44
- Technical
- Relative Strength Index (RSI)
- RVPH 61.01
- UONEK 59.20
- Support Level
- RVPH $0.40
- UONEK $0.63
- Resistance Level
- RVPH $0.48
- UONEK $0.69
- Average True Range (ATR)
- RVPH 0.05
- UONEK 0.04
- MACD
- RVPH 0.01
- UONEK 0.01
- Stochastic Oscillator
- RVPH 58.53
- UONEK 73.45
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.